Beauty Health Q4 EPS $(0.07), Inline, Sales $96.80M Beat $87.63M Estimate
Portfolio Pulse from Happy Mohamed
Beauty Health (NASDAQ:SKIN) reported Q4 losses of $(0.07) per share, aligning with analyst estimates, and sales of $96.80M, surpassing the $87.63M estimate. This represents a 240% decrease in earnings and a 1.36% decrease in sales from the previous year.
March 12, 2024 | 8:10 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Beauty Health reported Q4 EPS of $(0.07), in line with estimates, and sales of $96.80M, exceeding expectations. Year-over-year, earnings decreased by 240%, and sales saw a slight decline of 1.36%.
While Beauty Health met EPS estimates and exceeded sales forecasts, the significant decrease in earnings compared to the previous year and a slight decline in sales may temper investor enthusiasm. The alignment with EPS estimates and beating sales forecasts could be seen as positive, but the year-over-year performance indicates underlying challenges. Therefore, the short-term impact on SKIN's stock price is assessed as neutral.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100